Corrigendum to “The role of hepassocin in the development of non-alcoholic fatty liver disease” (Journal of Hepatology (2013) 59(5) (1065–1072) (S0168827813004145) (10.1016/j.jhep.2013.06.004));The role of Hepassocin in the development of non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 59, Issue 5, 2013, Pages 1065-1072

  Wu, Hung Tsung ^a,b   Lu, Feng Hwa ^b   Ou, Horng Yih ^b   Su, Yu Chu ^b   Hung, Hao Chang ^b   Wu, Jin Shang ^b   Yang, Yi Ching ^b   Wu, Chao Liang ^b   Chang, Chih Jen ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Fatty acids; Hepatic steatosis; Liver; Oleic acid; STAT3

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYL COENZYME A CARBOXYLASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID SYNTHASE; HEPASSOCIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LENTIVIRUS VECTOR; LIPOFECTAMINE; LIVER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEIC ACID; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ELEVATED BLOOD PRESSURE; ENZYME PHOSPHORYLATION; EXPERIMENTAL ANIMAL; FATTY LIVER; FEMALE; GENE DELETION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEPATITIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ACC-1; ACETYL-COA CARBOXYLASE-1; ERK1/2; EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2; FAS; FATTY ACID SYNTHASE; FATTY ACIDS; FFAS; FREE FATTY ACIDS; HCC; HEPASSOCIN; HEPATIC STEATOSIS; HEPATOCELLULAR CARCINOMA; HEPATOCYTE NUCLEAR FACTOR-1; HFD; HIGH FAT DIET; HNF-1; HPS; LIVER; NAFLD; NAFLD ACTIVITY SCORE; NAS; NASH; NON-ALCOHOLIC FATTY LIVER DISEASE; NON-ALCOHOLIC STEATOHEPATITIS; OA; OLEIC ACID; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; SREBP-1; STAT3; STEROL REGULATORY ELEMENT-BINDING PROTEIN-1;

AGED; ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; FIBRINOGEN; GENE DELETION; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPID METABOLISM; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEOPLASM PROTEINS; OLEIC ACID;

EID: 84885950639     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.11.006     Document Type: Erratum

References (27)

1. Z.M. Younossi, and C. Venkatesan A 2012 clinical update for internists in adult non-alcoholic fatty liver disease Panminerva Med 54 2012 29 37
2. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani Prevalence of and risk factors for non-alcoholic fatty liver disease: the dionysos nutrition and liver study Hepatology 42 2005 44 52
3. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
4. Q.M. Anstee, A.K. Daly, and C.P. Day Genetic modifiers of non-alcoholic fatty liver disease progression BBA Mol Basis Dis 1812 2011 1557 1566
5. G.M. Reaven The metabolic syndrome: requiescat in pace Clin Chem 51 2005 931 938
6. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
7. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
8. C. Postic, and J. Girard Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice J Clin Invest 118 2008 829 838
9. G. Cabibbo, M. Maida, C. Genco, M. Antonucci, and C. Comma Causes of and prevention strategies for hepatocellular carcinoma Semin Oncol 39 2012 374 383
10. H. Hara, H. Yoshimura, S. Uchida, Y. Toyoda, M. Aoki, and Y. Sakai Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity Biochim Biophys Acta 1520 2001 45 53
11. H. Hara, S. Uchida, H. Yoshimura, M. Aoki, Y. Toyoda, and Y. Sakai Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration Biochim Biophys Acta 1492 2000 31 44
12. C.Y. Li, C.Z. Cao, W.X. Xu, M.M. Cao, F. Yang, and L. Dong Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure Gut 59 2010 817 826
13. M.M. Cao, W.X. Xu, C.Y. Li, C.Z. Cao, Z.D. Wang, and J.W. Yao Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms J Cell Biochem 112 2011 2882 2890
14. H.T. Yu, M. Yu, C.Y. Li, Y.Q. Zhan, W.X. Xu, and Y.H. Li Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma J Biol Chem 284 2009 13335 13347
15. H.C. Hung, Y.C. Yang, H.Y. Ou, J.S. Wu, F.H. Lu, and C.J. Chang The relationship between impaired fasting glucose and self-reported sleep quality in a Chinese population Clin Endocrinol 78 2013 518 524
16. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment-insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man Diabetologia 28 1985 412 419
17. M.H. Farkas, L.L. Swift, A.H. Hasty, M.F. Linton, and S. Fazio The recycling of apolipoprotein E in primary cultures of mouse hepatocytes. Evidence for a physiologic connection to high density lipoprotein metabolism J Biol Chem 278 2003 9412 9417
18. H.T. Wu, W. Chen, K.C. Cheng, P.M. Ku, C.H. Yeh, and J.T. Cheng Oleic acid activates peroxisome proliferator-activated receptor delta to compensate insulin resistance in steatotic cells J Nutr Biochem 23 10 2012 1264 1270
19. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Non-alcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for non-alcoholic fatty liver disease Hepatology 41 2005 1313 1321
20. J. Kotzka, D. Müller-Wieland, G. Roth, L. Kremer, M. Munck, and S. Schürmann Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade J Lipid Res 41 2000 99 108
21. J.R. Lewis, and S.R. Mohanty Non-alcoholic fatty liver disease: a review and update Dig Dis Sci 55 2010 560 578
22. M. Lazo, and J.M. Clark The epidemiology of non-alcoholic fatty liver disease: a global perspective Semin Liver Dis 28 2008 339 350
23. A. Wree, A. Kahraman, G. Gerken, and A. Canbay Obesity affects the liver - The link between adipocytes and hepatocytes Digestion 83 2011 124 133
24. S.H. Ibrahim, R. Kohli, and G.J. Gores Mechanisms of lipotoxicity in NAFLD and clinical implications J Pediatr Gastroenterol Nutr 53 2011 131 140
25. Q. Liu, S. Bengmark, and S. Qu The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD) Lipids Health Dis 9 2010 42
26. N.C. Chavez-Tapia, and C. Tiribelli Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)? Gut 57 2008 1351 1353
27. N.F. Schwenzer, F. Springer, C. Schraml, N. Stefan, J. Machann, and F. Schick Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance J Hepatol 51 2009 433 445